What Analysts are Predicting For AbbVie Inc. (ABBV), Amgen Inc. (AMGN)?

What Analysts are Predicting For AbbVie Inc. (ABBV), Amgen Inc. (AMGN)?

What Analysts are Predicting For AbbVie Inc. (ABBV), Amgen Inc. (AMGN)?

Traders are more bullish on shares of the company of late as inferred by the fall in short interest. About 232 shares traded. It has underperformed by 6.07% the S&P500. 37,816 were reported by Delphi Management Incorporated Ma.

AbbVie Inc. (ABBV) shows its Return on Assets (ROA) value of 10 percent, while the Return on Equity (ROE) value is 119.7 percent and Return on Investment (ROI) value stands at 18 percent. The King Wealth Management Group Llc holds 44,209 shares with $2.77M value, up from 33,415 last quarter.

More notable recent AbbVie Inc (NYSE:ABBV) news were published by: Seekingalpha.com which released: "Recent Sale: AbbVie" on September 01, 2017, also Fool.com with their article: "The case for GlaxoSmithKline" published on September 08, 2017, Nasdaq.com published: "AbbVie Inc". It closed at $84.52 lastly. It has underperformed by 13.49% the S&P500.The move comes after 8 months positive chart setup for the $269.97M company.

Since March 16, 2017, it had 0 insider purchases, and 5 insider sales for $3.05 million activity. On Monday, May 1 the insider Alton Gregg H sold $341,529. About 5.81 million shares traded or 6.80% up from the average. The stock was sold at an average price of $71.00, for a total transaction of $13,712,301.00.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 48% are positive. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data. The rating was upgraded by TheStreet to "Buy" on Tuesday, August 11. Deutsche Bank initiated the shares of ABBV in report on Tuesday, March 15 with "Hold" rating. M Partners maintained Fred's, Inc. (NASDAQ:GILD) on Friday, February 12 with "Buy" rating. UBS maintained the shares of ABBV in report on Friday, October 23 with "Buy" rating.

Northern Ireland flood warning as yellow alert for rain issued
Very strong winds with speeds of 55-65mph look increasingly likely with wind speeds potentially reaching 75mph in exposed areas. Highest temperatures are expected to be between 14 and 16 degrees.

10/31/2016 - AbbVie Inc. was downgraded to "neutral" by analysts at Credit Suisse. As per Friday, September 18, the company rating was maintained by Scotia Capital. (NASDAQ:FRED) on Wednesday, November 2 with "Hold" rating. The rating was downgraded by JP Morgan on Thursday, September 8 to "Neutral". AbbVie accounts for 1.8% of Bainco International Investors' holdings, making the stock its 20th largest position. Its up 0.01, from 0.99 in 2016Q3.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. The stock had a trading volume of 4,641,354 shares. 12,367 are owned by Jnba. State Common Retirement Fund has invested 0.37% in AbbVie Inc (NYSE:ABBV). Harvey Limited Liability has 116,571 shares. 126.04 million shares or 3.04% less from 129.98 million shares in 2016Q3 were reported. It is 0.00% or $0 reaching $87 per share. Citigroup accumulated 989,968 shares or 0.06% of the stock. It also increased its holding in Cimarex Energy Co (NYSE:XEC) by 34,236 shares in the quarter, for a total of 77,632 shares, and has risen its stake in Deere & Co (NYSE:DE). Westchester Capital Inc holds 146,919 shares or 4.59% of its portfolio. Monetary Mngmt Gru holds 1.32% or 45,525 shares in its portfolio. Eaton Vance stated it has 0.57% of its portfolio in Gilead Sciences, Inc. (NYSE:ABBV) by 0.5% during the third quarter, Holdings Channel reports. Systematic LP reported 9,300 shares stake. Envestnet Asset Mgmt accumulated 1 shares. Fort Washington Investment Advisors Oh holds 0.14% of its portfolio in AbbVie Inc (NYSE:ABBV) for 129,933 shares. (NYSE:MRK). Moreover, Ariel Cap Advsrs Ltd Liability has 1.37% invested in Merck & Co., Inc.

Since May 4, 2017, it had 0 buys, and 5 selling transactions for $18.84 million activity. $5.59 million worth of AbbVie Inc (NYSE:ABBV) was sold by Schumacher Laura J. According to Thomson Reuters, sell-side analysts are forecasting a harmony target price of $187.00 on company shares. GONZALEZ RICHARD A had sold 71,235 shares worth $4.67 million. (NYSE:ABBV), with 6 analysts believing it is a strong buy. Therefore 54% are positive.

AbbVie Inc. on 6/29/2017 reported its EPS as $1.21 with the analysts projecting the EPS of the stock as $1.2. The stock of General Electric Company (NYSE:GE) earned "Outperform" rating by Bernstein on Friday, December 16. SunTrust initiated the stock with "Buy" rating in Wednesday, July 22 report. The firm has "Hold" rating given on Monday, June 12 by Oppenheimer. Jefferies has "Buy" rating and $9000 target. BidaskClub upgraded shares of AbbVie from a buy rating to a strong-buy rating in a research note on Saturday, June 10th. Credit Suisse Group reiterated a hold rating and issued a $65.00 target price on shares of AbbVie in a research note on Wednesday, June 7th. The firm has "Outperform" rating given on Friday, September 2 by Raymond James. Everpoint Asset Limited Liability Corporation holds 0.35% of its portfolio in AbbVie Inc (NYSE:ABBV) for 300,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Related news